“…An emerging focus in synthetic biology engineers microbes to integrate within specific niches in nature, artificial infrastructure and the human body (4)(5)(6)(7)(8)(9)(10)(11). Since genetic programming of bacteria enables them to sense and respond to physiological conditions in situ, this approach is poised to change existing paradigms for diagnosing and treating diseases such as inflammation (12,13), infection (14,15), and cancer (16)(17)(18). An essential element of this approach requires the precise regulation of microbial growth at disease sites, since uncontrolled bacterial replication can lead to severe side effects including tissue damage and septic shock (19,20).…”